All Stories

  1. Long COVID demographic and secondary care referral characteristics in primary care: analysis of anonymised primary care data from a multiethnic, deprived urban area in the UK
  2. Preventing medication nonadherence: a framework for interventions to support early engagement with treatment
  3. The challenges of living with Debilitating Symptom Complexes Attributed to Ticks (DSCATT) – A qualitative study
  4. Using a novel methodology to map Post-COVID services for children and young people in England: a web-based systematic search
  5. Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant)
  6. Investigating psychobiological causes and mechanisms in functional seizures and functional motor symptoms: Study protocol
  7. Reflections on the CODES trial for adults with dissociative seizures: what we found and considerations for future studies
  8. Exploring the Experiences of Living With the Post‐COVID Syndrome: A Qualitative Study
  9. Fatigue during the COVID-19 pandemic – prevalence and predictors: findings from a prospective cohort study
  10. “People don’t have the answers”: A qualitative exploration of the experiences of young people with Long COVID
  11. Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study
  12. Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors’ Rehabilitation Evalua...
  13. Illness perceptions, cognitive and behavioural responses to chronic breathlessness in individuals living with advanced respiratory disease: an observational study
  14. Changes in hair cortisol in a New Zealand community sample during the Covid-19 pandemic
  15. Mental health in the COVID-19 pandemic: A longitudinal analysis of the CLoCk cohort study
  16. Accelerated immune ageing is associated with COVID-19 disease severity
  17. How does cognitive behavior therapy for dissociative seizures work? A mediation analysis of the CODES trial
  18. Qualitative study of experience of acceptance and commitment therapy (ACT+) amongst Survivors' Rehabilitation Evaluation after Cancer (SURECAN) trial participants and therapists: A protocol.
  19. Which fatigue scale should I use? A Rasch analysis of two fatigue scales in inflammatory conditions
  20. Participant experiences of guided self-help Acceptance and Commitment Therapy for improving quality of life in muscle disease: a nested qualitative study within the ACTMus randomized controlled trial
  21. What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials
  22. Prevalence of sleep disturbances in patients with long COVID assessed by standardised questionnaires and diagnostic criteria: A systematic review and meta-analysis
  23. Cognitive behavioural therapy for neurologists
  24. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
  25. Children and Young People with Long COVID—Comparing Those Seen in Post-COVID Services with a Non-Hospitalised National Cohort: A Descriptive Study
  26. Chronic fatigue syndromes: real illnesses that people can recover from
  27. Objective and subjective neurocognitive functioning in functional motor symptoms and functional seizures: preliminary findings
  28. All-or-Nothing Behavior and Catastrophic Thinking Predict Fatigue in Inflammatory Bowel Disease: A Prospective Cohort Study
  29. Symptom Profiles of Children and Young People 12 Months after SARS-CoV-2 Testing: A National Matched Cohort Study (The CLoCk Study)
  30. Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitis
  31. Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis
  32. Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
  33. Coping After Breast Cancer: Protocol for a Randomized Controlled Trial of Stress Management eHealth Interventions
  34. Qualitative study of experience of acceptance and commitment therapy (ACT+) amongst Survivors' Rehabilitation Evaluation after Cancer (SURECAN) trial participants and therapists: A protocol.
  35. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
  36. Fatigue outcomes following COVID-19: a systematic review and meta-analysis
  37. Long COVID—six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: A national matched cohort study (The CLoCk) study
  38. A randomised, controlled, feasibility trial of an online, self-guided breathlessness supportive intervention (SELF-BREATHE) for individuals with chronic breathlessness due to advanced disease
  39. Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 months
  40. Increases in stress hormone levels in a UK population during the COVID-19 pandemic: A prospective cohort study
  41. The Cognitive and Behavioural Responses to Symptoms Questionnaire (CBRQ): Development, reliability and validity across several long‐term conditions
  42. Performance of the GAD-7 in adults with dissociative seizures
  43. The effects of sleep disturbance on dyspnoea and impaired lung function following COVID-19 hospitalisation: a prospective multi-centre cohort study
  44. Transdiagnostic therapy for persistent physical symptoms: A mediation analysis of the PRINCE secondary trial
  45. A systematic literature review of randomized controlled trials evaluating prognosis following treatment for adults with chronic fatigue syndrome
  46. Generalized Worry in Patients With Chronic Fatigue Syndrome Following Cognitive Behavioral Therapy: A Prospective Cohort Study in Secondary Care
  47. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
  48. Moderators of cognitive behavioural therapy treatment effects and predictors of outcome in the CODES randomised controlled trial for adults with dissociative seizures
  49. Evidence-Based Care for People with Chronic Fatigue Syndrome and Myalgic Encephalomyelitis
  50. Evaluating an interactive acceptance and commitment therapy (ACT) workshop delivered to trained therapists working with cancer patients in the United Kingdom: a mixed methods approach
  51. Reply
  52. Patients with chronic fatigue syndrome can improve with graded exercise therapy: Response to Vink et al. 2022*
  53. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study
  54. Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19
  55. The prevalence, incidence, prognosis and risk factors for symptoms of depression and anxiety in a UK cohort during the COVID-19 pandemic
  56. Six-month outcomes of the CODES randomised controlled trial of cognitive behavioural therapy for dissociative seizures: A secondary analysis
  57. A randomised controlled trial of acceptance and commitment therapy for improving quality of life in people with muscle diseases
  58. Why Do Patients With Gout Not Take Allopurinol?
  59. Psychological Predictors of Self-reported COVID-19 Outcomes: Results From a Prospective Cohort Study
  60. Chronic fatigue syndrome and occupational status: a retrospective longitudinal study
  61. Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention
  62. Evidence-Based Care for People with Chronic Fatigue Syndrome and Myalgic Encephalomyelitis
  63. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients
  64. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
  65. Discernment of mediator and outcome measurement in the PACE trial
  66. PRINCE Secondary: transdiagnostic cognitive behaviour therapy for persistent physical symptoms
  67. The role of lifetime stressors in adult fibromyalgia: a response to Joan S. Crawford's letter to the editor
  68. The development of an intervention to support uptake and adherence to antiretroviral therapy in people living with HIV: the SUPA intervention. A brief report
  69. Graded exercise therapy for patients with chronic fatigue syndrome in secondary care – a benchmarking study
  70. Cost effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome: the ACTIB randomised trial
  71. Validation of the PHQ-9 in adults with dissociative seizures
  72. Cognitive–behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT
  73. Efficacy of therapist-delivered transdiagnostic CBT for patients with persistent physical symptoms in secondary care: a randomised controlled trial
  74. Depression, anxiety and stress during the COVID-19 pandemic: results from a New Zealand cohort study on mental well-being
  75. Discernment of Mediator and Outcome Measurement in the PACE trial
  76. The role of lifetime stressors in adult fibromyalgia: systematic review and meta-analysis of case-control studies
  77. Paediatric chronic fatigue syndrome: 25 year perspective
  78. Fatigue outcomes following coronavirus or influenza virus infection: A systematic review and meta-analysis
  79. Patients’ Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study
  80. Mental Health of Keyworkers in the UK during the COVID-19 Pandemic: a Cross-sectional Analysis of a Community Cohort
  81. Correction to: Integrated GP care for patients with persistent physical symptoms: feasibility cluster randomised trial
  82. Integrated GP care for patients with persistent physical symptoms: feasibility cluster randomised trial
  83. The experience of trial participation, treatment approaches and perceptions of change among participants with dissociative seizures within the CODES randomized controlled trial: A qualitative study
  84. Cognitive behavioural therapy for chronic fatigue and chronic fatigue syndrome: outcomes from a specialist clinic in the UK
  85. <p>Experiences and Illness Perceptions of Patients with Functional Symptoms Admitted to Hyperacute Stroke Wards: A Mixed-Method Study</p>
  86. Cancer-related fatigue and functional impairment – Towards an understanding of cognitive and behavioural factors
  87. Attentional Processing and Interpretative Bias in Functional Neurological Disorder
  88. Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial
  89. Sleep problems in adolescents with CFS: A case-control study nested within a prospective clinical cohort
  90. Mental health in the UK during the COVID-19 pandemic: early observations
  91. Psychological and demographic characteristics of 368 patients with dissociative seizures: data from the CODES cohort
  92. Functional stroke symptoms: A prospective observational case series
  93. How and for whom does supportive adjustment to multiple sclerosis cognitive-behavioural therapy work? A mediated moderation analysis
  94. Cortisol levels in chronic fatigue syndrome and atypical depression measured using hair and saliva specimens
  95. Patients’ Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study (Preprint)
  96. Outcome measurement in functional neurological disorder: a systematic review and recommendations
  97. Can randomised control trial design identify the best way to use Twitter to disseminate research? (Preprint)
  98. Predicting first attendance at psychiatry appointments in patients with dissociative seizures
  99. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial
  100. Cognitive behavioural responses to envy: development of a new measure
  101. Persistent physical symptoms reduction intervention: a system change and evaluation in secondary care (PRINCE secondary) – a CBT-based transdiagnostic approach: study protocol for a randomised controlled trial
  102. Characteristics of 698 patients with dissociative seizures: A UK multicenter study
  103. Factors associated with work status in chronic fatigue syndrome
  104. Systemic low-grade inflammation and subsequent depressive symptoms: Is there a mediating role of physical activity?
  105. Protocol of a two arm randomised, multi-centre, 12-month controlled trial: evaluating the impact of a Cognitive Behavioural Therapy (CBT)-based intervention Supporting UPtake and Adherence to antiretrovirals (SUPA) in adults with HIV
  106. Author response to letter to the editor
  107. Persistent physical symptoms reduction intervention: a system change and evaluation (PRINCE)—integrated GP care for persistent physical symptoms: protocol for a feasibility and cluster randomised waiting list, controlled trial
  108. Psychometric properties of the Cognitive and Behavioural Responses Questionnaire (CBRQ) in adolescents with chronic fatigue syndrome
  109. Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial
  110. Depressive symptoms in adolescents with chronic fatigue syndrome (CFS): Are rates higher than in controls and do depressive symptoms affect outcome?
  111. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT
  112. However CFS is operationalised young people’s perspectives are important
  113. Cognitive and behavioural responses to symptoms in adolescents with chronic fatigue syndrome: A case-control study nested within a cohort
  114. The PACE trial of treatments for chronic fatigue syndrome: a response to WILSHIRE et al
  115. Perfectionism and beliefs about emotions in adolescents with chronic fatigue syndrome and their parents: a preliminary investigation in a case control study nested within a cohort
  116. Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome
  117. Psychological and demographic factors associated with fatigue and social adjustment in young people with severe chronic fatigue syndrome/myalgic encephalomyelitis: a preliminary mixed-methods study
  118. Adolescent and parent factors related to fatigue in paediatric multiple sclerosis and chronic fatigue syndrome: A comparative study
  119. ‘It’s the unknown’ – understanding anxiety: from the perspective of people with multiple sclerosis
  120. Does fatigue and distress in a clinical cohort of adolescents with chronic fatigue syndrome correlate with fatigue and distress in their parents?
  121. Key mechanisms of cognitive behavioural therapy in irritable bowel syndrome: The importance of gastrointestinal related cognitions, behaviours and general anxiety
  122. Childhood adversity as a transdiagnostic risk factor for affective disorders in adulthood: A systematic review focusing on biopsychosocial moderating and mediating variables
  123. Cognitive behaviour therapy for distress in people with inflammatory bowel disease: A benchmarking study
  124. Cognitive and Behavioral Differences Between Subtypes in Refractory Irritable Bowel Syndrome
  125. Illness beliefs of adolescents with CFS and their parents: the perceived causes of illness and beliefs about recovery
  126. Home-based family focused rehabilitation for adolescents with severe Chronic Fatigue Syndrome
  127. Patients’ perspectives on GP interactions after cognitive behavioural therapy for refractory IBS: a qualitative study in UK primary and secondary care
  128. Horses for courses: choosing an evidence-based psychological therapy for your patient
  129. How can we figure out how treatments work?
  130. Intervention planning for the REDUCE maintenance intervention: a digital intervention to reduce reulceration risk among patients with a history of diabetic foot ulcers
  131. Desperately seeking a cure: Treatment seeking and appraisal in irritable bowel syndrome
  132. The importance of cluster analysis for enhancing clinical practice: an example from irritable bowel syndrome
  133. Positive and negative affect mediate the bidirectional relationship between emotional processing and symptom severity and impact in irritable bowel syndrome
  134. Don't reject evidence from CFS therapies
  135. Cognitive-behavioural therapy for adult attention-deficit hyperactivity disorder: a proof of concept randomised controlled trial
  136. The presence of co-morbid mental health problems in a cohort of adolescents with chronic fatigue syndrome
  137. Review of systematic reviews of non-pharmacological interventions to improve quality of life in cancer survivors
  138. Cost-effectiveness of nurse-delivered cognitive behavioural therapy (CBT) compared to supportive listening (SL) for adjustment to multiple sclerosis
  139. Psychometric properties and factor structure of a shortened version of the Cognitive Behavioural Responses Questionnaire (CBRQ)
  140. A qualitative study exploring the experience of people with IBD and elevated symptoms of anxiety and low mood and the type of psychological help they would like
  141. The role of high expectations of self and social desirability in emotional processing in individuals with irritable bowel syndrome: A qualitative study
  142. Controversy over exercise therapy for chronic fatigue syndrome: Continuing the debate
  143. Cross-Cultural Study of Information Processing Biases in Chronic Fatigue Syndrome: Comparison of Dutch and UK Chronic Fatigue Patients
  144. COgnitive behavioural therapy versus standardised medical care for adults with Dissociative non-Epileptic Seizures (CODES): statistical and economic analysis plan for a randomised controlled trial
  145. The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome
  146. Family therapy for autism spectrum disorders
  147. Guided Self-Help for Patients with Chronic Fatigue Syndrome Prior to Starting Cognitive Behavioural Therapy: a Cohort Study
  148. “Lumping” and “splitting” medically unexplained symptoms: is there a role for a transdiagnostic approach?
  149. Web‐based interventions for the management of stress in the workplace: Focus, form, and efficacy
  150. ‘It feels sometimes like my house has burnt down, but I can see the sky’: A qualitative study exploring patients’ views of cognitive behavioural therapy for chronic fatigue syndrome
  151. A survey to determine usual care after cancer treatment within the United Kingdom national health service
  152. Same, Same But Different? Cognitive Behavioural Treatment Approaches for Paediatric CFS/ME and Depression
  153. Stress vulnerability in adolescents with chronic fatigue syndrome: experimental study investigating heart rate variability and skin conductance responses
  154. Response to the editorial by Dr Geraghty
  155. Heterogeneity in chronic fatigue syndrome – empirically defined subgroups from the PACE trial
  156. Do more people recover from chronic fatigue syndrome with cognitive behaviour therapy or graded exercise therapy than with other treatments?
  157. A pilot case series of a brief acceptance and commitment therapy (ACT)-based guided self-help intervention for improving quality of life and mood in muscle disorders
  158. A comparison of the Work and Social Adjustment Scale (WSAS) across different patient populations using Rasch analysis and exploratory factor analysis
  159. Fatigue and psychosocial variables in autoimmune rheumatic disease and chronic fatigue syndrome: A cross-sectional comparison
  160. Fatigue in an adult attention deficit hyperactivity disorder population: A trans-diagnostic approach
  161. An attention and interpretation bias for illness-specific information in chronic fatigue syndrome
  162. The specific needs of doctors with mental health problems: qualitative analysis of doctor-patients' experiences with the Practitioner Health Programme
  163. A systematic review of anxiety amongst people with Multiple Sclerosis
  164. “It feels like wearing a giant sandbag.” Adolescent and parent perceptions of fatigue in paediatric multiple sclerosis
  165. Cognitive Interventions and Nutritional Supplements (The CINS Trial)
  166. Maximizing potential impact of experimental research into cognitive processes in health psychology: A systematic approach to material development
  167. Attentional and interpretive bias towards illness-related information in chronic fatigue syndrome: A systematic review
  168. Measurement error, time lag, unmeasured confounding: Considerations for longitudinal estimation of the effect of a mediator in randomised clinical trials
  169. Emotional suppression in chronic fatigue syndrome: Experimental study.
  170. Chronic fatigue syndrome: Comparing outcomes in White British and Black and minority ethnic patients after cognitive–behavioural therapy
  171. Cognitive behaviour therapy for chronic fatigue syndrome: Differences in treatment outcome between a tertiary treatment centre in the United Kingdom and the Netherlands
  172. Complementary and alternative healthcare use by participants in the PACE trial of treatments for chronic fatigue syndrome
  173. A systematic review of the psychological correlates of adjustment outcomes in adults with inflammatory bowel disease
  174. Is chronic fatigue syndrome heterogeneous? A review of the literature and new study of the lumping versus splitting debate for functional somatic syndromes
  175. Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study
  176. Mortality of people with chronic fatigue syndrome: a retrospective cohort study in England and Wales from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Clinical Record Interactive Search (CRIS) Register
  177. Patient reaction to the PACE trial – Authors' reply
  178. Comment on: ‘Reports of recovery in chronic fatigue syndrome may present less than meets the eye’
  179. Establishing how psychological therapies work: the importance of mediation analysis
  180. Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial
  181. Understanding fatigue in paediatric multiple sclerosis: a systematic review of clinical and psychosocial factors
  182. Family therapy for autism spectrum disorders
  183. Psychological correlates of fatigue in rheumatoid arthritis: A systematic review
  184. Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irrita...
  185. COgnitive behavioural therapy vs standardised medical care for adults with Dissociative non-Epileptic Seizures (CODES): a multicentre randomised controlled trial protocol
  186. The most popular terms for medically unexplained symptoms: The views of CFS patients
  187. Methods and outcome reporting in the PACE trial–Author's reply
  188. Model of Understanding Fatigue After Stroke
  189. Rehabilitative therapies for chronic fatigue syndrome: a secondary mediation analysis of the PACE trial
  190. The planning, implementation and publication of a complex intervention trial for chronic fatigue syndrome: the PACE trial
  191. Cognitive behaviour therapy for adults with autism spectrum disorders and psychiatric co-morbidity: A review
  192. Prevalence and predictors of recovery from chronic fatigue syndrome in a routine clinical practice
  193. Evaluating Interactive Fatigue Management Workshops for Occupational Health Professionals in the United Kingdom
  194. Cortisol output in adolescents with chronic fatigue syndrome: Pilot study on the comparison with healthy adolescents and change after cognitive behavioural guided self-help treatment
  195. Protocol for a proof of concept randomized controlled trial of cognitive-behavioural therapy for adult ADHD as a supplement to treatment as usual, compared with treatment as usual alone
  196. 'You feel you've been bad, not ill': Sick doctors' experiences of interactions with the General Medical Council
  197. Adverse events and deterioration reported by participants in the PACE trial of therapies for chronic fatigue syndrome
  198. Competences Required for the Delivery of High and Low-Intensity Cognitive Behavioural Interventions for Chronic Fatigue, Chronic Fatigue Syndrome/ME and Irritable Bowel Syndrome
  199. Fatigue and Depression in Sick-Listed Chronic Low Back Pain Patients
  200. Exercise therapy for chronic fatigue syndrome (individual patient data)
  201. A review of the predisposing, precipitating and perpetuating factors in Chronic Fatigue Syndrome in children and adolescents
  202. Chronic Fatigue Syndrome
  203. A multicentre postal survey investigating the contribution of illness perceptions, coping and optimism to quality of life and mood in adults with muscle disease
  204. PACE trial authors' reply to letter by Kindlon
  205. Childhood stressors in the development of fatigue syndromes: a review of the past 20 years of research
  206. Cognitive behaviour therapy for common mental disorders in people with Multiple Sclerosis: A bench marking study
  207. Change and processes of change within interventions to promote adjustment to multiple sclerosis: Learning from patient experiences
  208. Pain in chronic fatigue syndrome: response to rehabilitative treatments in the PACE trial
  209. Mechanisms of change underlying the efficacy of cognitive behaviour therapy for chronic fatigue syndrome in a specialist clinic: a mediation analysis
  210. Corrigendum to “Telephone-based guided self-help for adolescents with chronic fatigue syndrome: A non-randomised cohort study” [Behav Res Ther 50 (5) (2012) 304–312]
  211. Letter to the Editor: Response to correspondence concerning ‘Recovery from chronic fatigue syndrome after treatments in the PACE trial’
  212. Separating emotions from consequences in muscle disease: Comparing beneficial and unhelpful illness schemata to inform intervention development
  213. Recovery from chronic fatigue syndrome after treatments given in the PACE trial
  214. Doctors and dentists with mental ill health and addictions: Outcomes of treatment from the Practitioner Health Programme
  215. A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan
  216. A randomized controlled trial of cognitive behavioral therapy (CBT) for adjusting to multiple sclerosis (the saMS trial): Does CBT work and for whom does it work?
  217. Family-focused cognitive behaviour therapy versus psycho-education for adolescents with chronic fatigue syndrome: Long-term follow-up of an RCT
  218. Experiences of young people who have undergone the Lightning Process to treat chronic fatigue syndrome/myalgic encephalomyelitis - a qualitative study
  219. Adaptive Pacing, Cognitive Behaviour Therapy, Graded Exercise, and Specialist Medical Care for Chronic Fatigue Syndrome: A Cost-Effectiveness Analysis
  220. Cognitions, behaviours and co-morbid psychiatric diagnoses in patients with chronic fatigue syndrome
  221. Development and preliminary evaluation of a psychosocial intervention for modifying psychosocial risk factors associated with foot re-ulceration in diabetes
  222. Telephone-based guided self-help for adolescents with chronic fatigue syndrome: A non-randomised cohort study
  223. Chronic fatigue syndrome: treatment without a cause
  224. PACE trial clarification
  225. Shame! Self-stigmatisation as an obstacle to sick doctors returning to work: a qualitative study: Table 1
  226. The role of acceptance in chronic fatigue syndrome
  227. Five-year follow-up of a cohort of people with their first diabetic foot ulcer: the persistent effect of depression on mortality
  228. Long-term sickness absence among patients with chronic fatigue syndrome
  229. Cognitive Behaviour Therapy for Chronic Fatigue Syndrome in Adults: Face to Face versus Telephone Treatment - A Randomized Controlled Trial
  230. Measuring disability in patients with chronic fatigue syndrome: reliability and validity of the Work and Social Adjustment Scale
  231. Nurse-led psychological interventions to improve diabetes control: Assessing competencies
  232. Emotion recognition and emotional theory of mind in chronic fatigue syndrome
  233. Protocol for the Cognitive Interventions and Nutritional Supplements (CINS) trial: A randomized controlled multicenter trial of a brief intervention (BI) versus a BI plus cognitive behavioral treatment (CBT) versus nutritional supplements for patients ...
  234. Adolescents with severe chronic fatigue syndrome can make a full recovery
  235. The PACE trial in chronic fatigue syndrome – Authors' reply
  236. Mediators of change in cognitive behaviour therapy and mebeverine for irritable bowel syndrome
  237. Developing a web-based stress management intervention for occupational support workers
  238. Doctors vulnerable to psychological distress and addictions: Treatment from the Practitioner Health Programme
  239. Motivational enhancement therapy with and without cognitive behaviour therapy for Type 1 diabetes: economic evaluation from a randomized controlled trial
  240. Emotional expression, self-silencing, and distress tolerance in anorexia nervosa and chronic fatigue syndrome
  241. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial
  242. Therapist effects in routine psychotherapy practice: An account from chronic fatigue syndrome
  243. Review of literature on the mental health of doctors: Are specialist services needed?
  244. Does the Heterogeneity of Chronic Fatigue Syndrome Moderate the Response to Cognitive Behaviour Therapy? An Exploratory Study
  245. Cognitive and behavioural correlates of different domains of psychological adjustment in early-stage multiple sclerosis
  246. Fatigue in rheumatoid arthritis: time for a conceptual model
  247. The development of the irritable bowel syndrome-behavioral responses questionnaire
  248. Measuring fatigue in clinical and community settings
  249. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: A pilot RCT
  250. A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: A Diabetes and Psychological Therapies (ADaPT) study.
  251. Personality and perfectionism in chronic fatigue syndrome: A closer look
  252. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care
  253. The Beliefs about Emotions Scale: Validity, reliability and sensitivity to change
  254. Cognitive behavioural therapy and psycho-education for chronic fatigue syndrome in young people: Reflections from the families' perspective
  255. Factors associated with acute fatigue in primary care
  256. Family-focused cognitive behaviour therapy versus psycho-education for chronic fatigue syndrome in 11- to 18-year-olds: a randomized controlled treatment trial
  257. Chronic fatigue syndrome in adolescents: Do parental expectations of their child's intellectual ability match the child's ability?
  258. Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome?
  259. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome
  260. A review of psychological correlates of adjustment in patients with multiple sclerosis
  261. Motivational Enhancement Therapy with and without Cognitive Behavior Therapy to Treat Type 1 Diabetes
  262. The neural correlates of fatigue: an exploratory imaginal fatigue provocation study in chronic fatigue syndrome
  263. Cost-effectiveness of cognitive behaviour therapy in addition to mebeverine for irritable bowel syndrome
  264. A Randomized Controlled Trial of Cognitive Behavior Therapy for Multiple Sclerosis Fatigue
  265. Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer
  266. Gulf War Illness: Lessons from medically unexplained symptoms
  267. The cognitive behavioural model of medically unexplained symptoms: A theoretical and empirical review
  268. Investigating the active ingredients of cognitive behaviour therapy and counselling for patients with chronic fatigue in primary care: Developing a new process measure to assess treatment fidelity and predict outcome
  269. The relationship between chronic fatigue and somatization syndrome: A general population survey
  270. Cognitive-behaviour therapy for chronic fatigue syndrome: Comparison of outcomes within and outside the confines of a randomised controlled trial
  271. A Cohort Study of People With Diabetes and Their First Foot Ulcer
  272. Protocol for the PACE trial: A randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with t...
  273. Incidence, Prognosis, and Risk Factors for Fatigue and Chronic Fatigue Syndrome in Adolescents: A Prospective Community Study
  274. Cross-cultural validation of the Chalder Fatigue Questionnaire in Brazilian primary care
  275. Probing the Working Memory System in Chronic Fatigue Syndrome: A Functional Magnetic Resonance Imaging Study Using the n-Back Task
  276. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial
  277. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial
  278. Eating disorders and irritable bowel syndrome: is there a link?
  279. What advice do patients with infectious mononucleosis report being given by their general practitioner?
  280. Treatments for chronic fatigue syndrome
  281. The Behavioural Responses to Illness Questionnaire (BRIQ): a new predictive measure of medically unexplained symptoms following acute infection
  282. A randomised controlled trial of a psycho-educational intervention to aid recovery in infectious mononucleosis
  283. Salivary cortisol response to awakening in chronic fatigue syndrome
  284. Depersonalisation disorder: a cognitive–behavioural conceptualisation
  285. Chronic fatigue syndrome in children: a cross sectional survey
  286. Illness perceptions and levels of disability in patients with chronic fatigue syndrome and rheumatoid arthritis
  287. Epidemiology of chronic fatigue syndrome and self reported myalgic encephalomyelitis in 5-15 year olds: cross sectional study
  288. Predictors of fatigue following the onset of infectious mononucleosis
  289. Childhood experiences of illness and parenting in adults with Chronic Fatigue Syndrome
  290. The relationship between illness attributions and attributional style in Chronic Fatigue Syndrome
  291. Predictors of outcome in a fatigued population in primary care following a randomized controlled trial
  292. Underlying self-esteem in chronic fatigue syndrome
  293. Family cognitive behaviour therapy for chronic fatigue syndrome: an uncontrolled study
  294. Long-Term Outcome of Cognitive Behavior Therapy Versus Relaxation Therapy for Chronic Fatigue Syndrome: A 5-Year Follow-Up Study
  295. Defensive coping styles in chronic fatigue syndrome
  296. Prevalence of Gulf war veterans who believe they have Gulf war syndrome: questionnaire study
  297. Chronic fatigue syndrome
  298. Extracts from "Clinical Evidence": Chronic fatigue syndrome
  299. Self-help treatment of chronic fatigue in the community: A randomized controlled trial
  300. Chronic fatigue syndrome
  301. Chronic fatigue in the community: ‘A question of attribution’
  302. A Comparison of the Characteristics of Chronic Fatigue Syndrome in Primary and Tertiary Care
  303. Chronic fatigue syndrome
  304. Viral illness and chronic fatigue (syndrome)
  305. Postinfectious fatigue: prospective cohort study in primary care
  306. Cognitive behavior therapy for chronic fatigue syndrome
  307. Chronic fatigue syndrome: a follow up study.
  308. Population based study of fatigue and psychological distress
  309. Development of a fatigue scale
  310. Cognitive behaviour therapy in chronic fatigue syndrome.
  311. Acyclovir Treatment of the Chronic Fatigue Syndrome
  312. Cognitive Behavioral Based Treatments for Psychogenic Nonepileptic Seizures